Is AVTR or BNGO more undervalued in 2026?

CirclFi compares Avantor, Inc. (AVTR) and Bionano Genomics, Inc. (BNGO) using 13 institutional-grade valuation models. AVTR has a Quality of Company score of 6.9/10 while BNGO scores 6.0/10.

Which is a better buy — AVTR or BNGO?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do AVTR and BNGO valuations compare?

AVTR at $9.12 and BNGO at $1.24 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

AVTR vs BNGO Valuation Comparison 2026 — Intrinsic Value Analysis

AVTR

Laboratory Analytical Instruments

Avantor, Inc.

Quality

6.9

out of 10

Value Trap

LOW

Price

$9.12

Last close

Models

12/13

Active

BNGO

Laboratory Analytical Instruments

Bionano Genomics, Inc.

Quality

6.0

out of 10

Value Trap

LOW

Price

$1.24

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	AVTR Fair Value	AVTR Upside	BNGO Fair Value	BNGO Upside
Bayesian DCF	Intrinsic	$6.37	-30.1%	$0.25	-79.6%
Earnings Power Value	Intrinsic	$17.03	+86.8%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$7.40	-18.8%	$0.50	-59.6%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for AVTR vs BNGO — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

AVTR vs BNGO — Which Stock Is More Undervalued?

AVTR scores higher with a 6.9/10 quality rating vs BNGO's 6.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Avantor, Inc. (AVTR) and Bionano Genomics, Inc. (BNGO) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

AVTR currently trades at $9.12 with a QOC of 6.9/10, while BNGO trades at $1.24 with a QOC of 6.0/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).